This is a preview of subscription content, log in via an institution to check access.
Notes
2015 Australian dollars
Reference
Ademi Z, et al. Clinical and Cost Effectiveness of Apixaban Compared to Aspirin in Patients with Atrial Fibrillation: An Australian Perspective. Applied Health Economics and Health Policy : 4 Oct 2016. Available from: URL: http://doi.org/10.1007/s40258-016-0283-9
Rights and permissions
About this article
Cite this article
Apixaban cost effective in patients with AF in Australia. PharmacoEcon Outcomes News 764, 7 (2016). https://doi.org/10.1007/s40274-016-3456-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3456-8